Patent details

91590 Product Name: "Lacosamide ou un de ses sels pharmaceutiquement acceptable (VIMPAT®)"

Basic Information

Publication number:
91590
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP027274372
Legal Status:
Lapsed
Application number:
91590
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
EU/1/08/470/001-016 - Vimpat - Lacosamide
Marketing Authorization Type:
Marketing Authorization Date:
29/08/2008
Marketing Authorization Status:
Accepted
Marketing Authorization Country:

Dates

Filing date:
05/08/2009
First Marketing Authorization date:
29/08/2008
Grant date:
05/10/2009
Activation date:
Publication date:
05/10/2009
Lapsed date:
19/03/2022
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
29/08/2023
SPC Extension Expiration:
29/08/2023
Rejection date:
Withdrawal date:

Owner

From:
27/10/2010
 
 

Name:
UCB PHARMA GMBH
Address:
ALFRED NOBEL STRASSE 10, 40789, MONHEIM, Germany (DE)

History of Owners

From:
05/08/2009
To:
26/10/2010

Name:
SCHWARZ PHARMA AG
Address:
Alfred-Nobel-Strasse 10, 40789 Monheim/Rhld., Germany (DE)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
05/08/2009
Address:
Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
To:

Inventor

Name:
SELVE Norma
Address:
Germany (DE)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages